Evolved Nanomaterial Sciences

Evolved Nanomaterial Sciences (ENS) is a biotechnology tools company that specializes in advanced chiral separation technologies for the pharmaceutical industry. The company leverages proprietary nanomaterial-based stationary phases to provide superior resolution of enantiomers compared to traditional chromatography methods. By improving the speed and precision of chiral separations, ENS helps researchers accelerate the development of single-enantiomer drugs, which are critical for ensuring therapeutic safety and efficacy. Their platform is applicable across the drug discovery pipeline, from early-stage analytical chemistry to larger-scale preparative purification. ENS aims to solve the 'chiral bottleneck' in small molecule drug development through its innovative material science approach.